TFS Capital’s Idexx Laboratories IDXX Stock Holding History

TFS Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-5,514	Closed	-$335K	–	1226
2014 Q1	$335K	Buy	+5,514	New	+$329K	0.02%	958

Other funds holding IDXX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

TFS Capital's IDXX Position: Q2 2014 in Review

TFS Capital sold out of Idexx Laboratories (IDXX) in Q2 2014, closing a stake of 5,514 shares — an estimated $335K sold.

TFS Capital first reported a position in IDXX in Q1 2014 and held it in 1 quarter. The position peaked at $335K in Q1 2014. 306 funds tracked by Wall St. Rank hold IDXX as of Q2 2014.

TFS Capital reported no remaining Idexx Laboratories position as of Q2 2014 after selling out during the quarter.
TFS Capital sold 5,514 Idexx Laboratories shares in Q2 2014, an estimated $335K.
TFS Capital first reported a position in Idexx Laboratories in Q1 2014 and held it in 1 quarter.
TFS Capital's Idexx Laboratories position peaked at $335K in Q1 2014.
306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2014.

Based on TFS Capital's 13F filing for Q2 2014, filed 21 Jul 2014.